Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),Pharmacology
Reference11 articles.
1. US Food and Drug Administration. Rybelsus® (semaglutide) tablets: prescribing information; 2023. https://www.accessdata.fda.gov/spl/data/fa74bbc6-5386-425e-8d4a-6151795ba57b/fa74bbc6-5386-425e-8d4a-6151795ba57b.xml. Accessed March 31, 2022.
2. Buckley ST, Bækdal TA, Vegge A, Maarbjerg SJ, Pyke C, Ahnfelt-Ronne J, et al. Transcellular stomach absorption of a derivatized glucagon-like peptide-1 receptor agonist. Sci Transl Med. 2018;10(467):eaar7047. https://doi.org/10.1126/scitranslmed.aar7047.
3. Bækdal TA, Breitschaft A, Donsmark M, Maarbjerg SJ, Sondergaard FL, Borregaard J. Effect of various dosing conditions on the pharmacokinetics of oral semaglutide, a human glucagon-like peptide-1 analogue in a tablet formulation. Diabetes Ther. 2021;12(7):1915–27. https://doi.org/10.1007/s13300-021-01078-y.
4. Bækdal TA, Thomsen M, Kupcova V, Hansen CW, Anderson TW. Pharmacokinetics, safety, and tolerability of oral semaglutide in subjects with hepatic impairment. J Clin Pharmacol. 2018;58(10):1314–23. https://doi.org/10.1002/jcph.1131.
5. Bækdal TA, Breitschaft A, Navarria A, Hansen CW. A randomised study investigating the effect of omeprazole on the pharmacokinetics of oral semaglutide. Expert Opin Drug Metab Toxicol. 2018;14(8):869–77. https://doi.org/10.1080/17425255.2018.1488965.
Cited by
5 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献